{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:47:55Z","timestamp":1761295675590,"version":"build-2065373602"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,10,24]]},"DOI":"10.7759\/cureus.95292","type":"journal-article","created":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:42:53Z","timestamp":1761295373000},"source":"Crossref","is-referenced-by-count":0,"title":["Secondary Hemophagocytic Lymphohistiocytosis in a Patient With Crohn\u2019s Disease Receiving Infliximab: A Diagnostic Challenge"],"prefix":"10.7759","author":[{"given":"Muneer","family":"Shoukath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ananthu","family":"Sobhanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajibola","family":"Omotosho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nidhisha","family":"Kanakambujan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mrinalini B","family":"Nandakumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bushra","family":"Jamil","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2018894618","article-title":"Recommendations for the management of hemophagocytic lymphohistiocytosis in adults","volume":"133","author":"La Ros\u00e9e P","year":"2019","unstructured":"La Ros\u00e9e P, Horne A, Hines M, et al.. Recommendations for the management of hemophagocytic lymphohistiocytosis in adults. Blood. 2019, 133:2465-2477. 10.1182\/blood.2018894618","journal-title":"Blood"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.2147\/JBM.S46255","article-title":"Hemophagocytic lymphohistiocytosis: review of etiologies and management","volume":"5","author":"George MR","year":"2014","unstructured":"George MR. Hemophagocytic lymphohistiocytosis: review of etiologies and management. J Blood Med. 2014, 5:69-86. 10.2147\/JBM.S46255","journal-title":"J Blood Med"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21039","article-title":"HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis","volume":"48","author":"Henter JI","year":"2007","unstructured":"Henter JI, Horne A, Aric\u00f3 M, et al.. HLH-2004: Diagnostic and therapeutic guidelines for hemophagocytic lymphohistiocytosis. Pediatr Blood Cancer. 2007, 48:124-131. 10.1002\/pbc.21039","journal-title":"Pediatr Blood Cancer"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-01-551622","article-title":"How I treat hemophagocytic lymphohistiocytosis in the adult patient","volume":"125","author":"Schram AM","year":"2015","unstructured":"Schram AM, Berliner N. How I treat hemophagocytic lymphohistiocytosis in the adult patient. Blood. 2015, 125:2908-2914. 10.1182\/blood-2015-01-551622","journal-title":"Blood"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.5114\/pg.2015.48995","article-title":"Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection","volume":"10","author":"Li Y","year":"2015","unstructured":"Li Y, Xia X, Zhang J, et al.. Haemophagocytic lymphohistiocytosis in inflammatory bowel disease with virus infection. Prz Gastroenterol. 2015, 10:78-82. 10.5114\/pg.2015.48995","journal-title":"Prz Gastroenterol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1007\/s10620-020-06252-z","article-title":"Hemophagocytic lymphohistiocytosis occurring in inflammatory bowel disease: systematic review","volume":"66","author":"Coburn ES","year":"2021","unstructured":"Coburn ES, Siegel CA, Winter M, Shah ED. Hemophagocytic lymphohistiocytosis occurring in inflammatory bowel disease: systematic review. Dig Dis Sci. 2021, 66:843-854. 10.1007\/s10620-020-06252-z","journal-title":"Dig Dis Sci"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1186\/s13045-024-01621-x","article-title":"Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms","volume":"17","author":"Wu Y","year":"2024","unstructured":"Wu Y, Sun X, Kang K, Yang Y, Li H, Zhao A, Niu T. Hemophagocytic lymphohistiocytosis: current treatment advances, emerging targeted therapy and underlying mechanisms. J Hematol Oncol. 2024, 17:106. 10.1186\/s13045-024-01621-x","journal-title":"J Hematol Oncol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1016\/j.critrevonc.2017.03.023","article-title":"Similar but not the same: differential diagnosis of HLH and sepsis","volume":"114","author":"Machowicz R","year":"2017","unstructured":"Machowicz R, Janka G, Wiktor-Jedrzejczak W. Similar but not the same: differential diagnosis of HLH and sepsis. Crit Rev Oncol Hematol. 2017, 114:1-12. 10.1016\/j.critrevonc.2017.03.023","journal-title":"Crit Rev Oncol Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(13)61048-X","article-title":"Adult haemophagocytic syndrome","volume":"383","author":"Ramos-Casals M","year":"2014","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, L\u00f3pez-Guillermo A, Khamashta MA, Bosch X. Adult haemophagocytic syndrome. Lancet. 2014, 383:1503-1516. 10.1016\/S0140-6736(13)61048-X","journal-title":"Lancet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-10-602607","article-title":"Marked hyperferritinemia does not predict for HLH in the adult population","volume":"125","author":"Schram AM","year":"2015","unstructured":"Schram AM, Campigotto F, Mullally A, Fogerty A, Massarotti E, Neuberg D, Berliner N. Marked hyperferritinemia does not predict for HLH in the adult population. Blood. 2015, 125:1548-1552. 10.1182\/blood-2014-10-602607","journal-title":"Blood"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1097\/HS9.0000000000000797","article-title":"Temporal trends in the incidence of hemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018","volume":"6","author":"West J","year":"2022","unstructured":"West J, Stilwell P, Liu H, et al.. Temporal trends in the incidence of hemophagocytic lymphohistiocytosis: a nationwide cohort study from England 2003-2018. Hemasphere. 2022, 6:e797. 10.1097\/HS9.0000000000000797","journal-title":"Hemasphere"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1159\/000506514","article-title":"Hemophagocytic lymphohistiocytosis and inflammatory bowel disease: case report and systematic review","volume":"5","author":"Brambilla B","year":"2020","unstructured":"Brambilla B, Barbosa AM, Scholze CD, et al.. Hemophagocytic lymphohistiocytosis and inflammatory bowel disease: case report and systematic review. Inflamm Intest Dis. 2020, 5:49-58. 10.1159\/000506514","journal-title":"Inflamm Intest Dis"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1093\/qjmed\/hcx183","article-title":"Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis","volume":"111","author":"Zhou M","year":"2018","unstructured":"Zhou M, Li L, Zhang Q, et al.. Clinical features and outcomes in secondary adult hemophagocytic lymphohistiocytosis. QJM. 2018, 111:23-31. 10.1093\/qjmed\/hcx183","journal-title":"QJM"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2011-03-278127","article-title":"How I treat hemophagocytic lymphohistiocytosis","volume":"118","author":"Jordan MB","year":"2011","unstructured":"Jordan MB, Allen CE, Weitzman S, Filipovich AH, McClain KL. How I treat hemophagocytic lymphohistiocytosis. Blood. 2011, 118:4041-4052. 10.1182\/blood-2011-03-278127","journal-title":"Blood"},{"key":"ref15","unstructured":"National Specialty Report. HLH guide v1.3. (2024). https:\/\/gettingitrightfirsttime.co.uk\/wp-content\/uploads\/2025\/06\/HLH-Guide-final-version-v1.3-June-2025.pdf.."}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/404716-secondary-hemophagocytic-lymphohistiocytosis-in-a-patient-with-crohns-disease-receiving-infliximab-a-diagnostic-challenge","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:42:56Z","timestamp":1761295376000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/404716-secondary-hemophagocytic-lymphohistiocytosis-in-a-patient-with-crohns-disease-receiving-infliximab-a-diagnostic-challenge"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,24]]},"references-count":15,"URL":"https:\/\/doi.org\/10.7759\/cureus.95292","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10,24]]}}}